Eleonora Panfili
Perugia, 06132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Discovery of a Dual IDO1/TDO Inhibitor That Modulates Enzymatic Activity and IDO1/SHP-2 Signaling.
Journal: Journal of medicinal chemistry
Published: July 22, 2026
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1.
Journal: ACS pharmacology & translational science
Published: May 03, 2024
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells.
Journal: Frontiers in immunology
Published: November 29, 2023
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function.
Journal: International journal of molecular sciences
Published: September 18, 2023
Unrevealing the Role of TLRs in the Pathogenesis of Autoimmune Disease by Using Mouse Model of Diabetes.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 21, 2023
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder.
Journal: Frontiers in clinical diabetes and healthcare
Published: February 21, 2023
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.
Journal: Oncoimmunology
Published: February 03, 2023
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.
Journal: Frontiers in immunology
Published: December 30, 2022
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine.
Journal: eLife
Published: December 29, 2022
Last Updated: 09/26/2026